ArticlePloS one2026
More than a digestive disorder: Perceived stigma in inflammatory bowel disease patients.
Article in PloS one, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundInflammatory bowel disease (IBD) is a chronic condition characterized by symptoms that are often difficult to conceal and may expose patients to negative social reactions. Beyond physical burden, stigma represents an important but underrecognized psychosocial challenge in IBD, potentially affecting social functioning and disease management. To determine the prevalence of perceived stigma among patients with IBD and to evaluate its association with disease subtype, sociodemographic characteristics, clinical features, and self-esteem.
methodsA total of 146 patients with IBD under regular follow-up were included in this cross-sectional study. Perceived stigma was assessed using ten disease-specific yes/no items reflecting real-life stigma-related experiences. Sociodemographic data, clinical characteristics, and self-esteem levels measured by the Rosenberg Self-Esteem Scale were recorded. Patients were classified as experiencing stigma if they endorsed at least one stigma item.
resultsOverall, 63.0% of patients reported at least one stigma-related experience. The most frequently reported manifestations were social avoidance and discomfort in public settings, while overt discrimination was less common. The distribution of stigma-related experiences was largely similar between Crohn's disease and ulcerative colitis patients. Individuals reporting stigma were significantly younger and had a younger age at diagnosis compared to those without stigma. No significant differences were observed with respect to gender, marital status, education, employment, income, disease subtype, surgical history, or comorbidities. Patients experiencing stigma had significantly lower self-esteem scores than those without stigma.
conclusionPerceived stigma is common among patients with IBD, particularly among younger individuals, and is more often expressed as social discomfort and avoidance rather than explicit discrimination. These findings highlight stigma as an important psychosocial dimension of IBD that warrants greater clinical attention. Integrating psychosocial support into routine care may help mitigate stigma-related consequences and improve overall disease management. Longitudinal studies are needed to clarify the long-term impact of stigma on disease outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.